1. Home
  2. TYRA vs HLF Comparison

TYRA vs HLF Comparison

Compare TYRA & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • HLF
  • Stock Information
  • Founded
  • TYRA 2018
  • HLF 1980
  • Country
  • TYRA United States
  • HLF United States
  • Employees
  • TYRA N/A
  • HLF N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • HLF Other Pharmaceuticals
  • Sector
  • TYRA Health Care
  • HLF Health Care
  • Exchange
  • TYRA Nasdaq
  • HLF Nasdaq
  • Market Cap
  • TYRA 812.7M
  • HLF 703.0M
  • IPO Year
  • TYRA 2021
  • HLF N/A
  • Fundamental
  • Price
  • TYRA $15.36
  • HLF $8.50
  • Analyst Decision
  • TYRA Strong Buy
  • HLF Buy
  • Analyst Count
  • TYRA 5
  • HLF 5
  • Target Price
  • TYRA $31.00
  • HLF $9.90
  • AVG Volume (30 Days)
  • TYRA 599.6K
  • HLF 2.8M
  • Earning Date
  • TYRA 11-07-2024
  • HLF 10-30-2024
  • Dividend Yield
  • TYRA N/A
  • HLF N/A
  • EPS Growth
  • TYRA N/A
  • HLF N/A
  • EPS
  • TYRA N/A
  • HLF 0.85
  • Revenue
  • TYRA N/A
  • HLF $5,000,700,000.00
  • Revenue This Year
  • TYRA N/A
  • HLF N/A
  • Revenue Next Year
  • TYRA N/A
  • HLF $1.99
  • P/E Ratio
  • TYRA N/A
  • HLF $9.96
  • Revenue Growth
  • TYRA N/A
  • HLF N/A
  • 52 Week Low
  • TYRA $10.60
  • HLF $6.59
  • 52 Week High
  • TYRA $29.60
  • HLF $15.66
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 34.38
  • HLF 61.73
  • Support Level
  • TYRA $15.04
  • HLF $7.62
  • Resistance Level
  • TYRA $16.51
  • HLF $8.49
  • Average True Range (ATR)
  • TYRA 0.94
  • HLF 0.42
  • MACD
  • TYRA 0.04
  • HLF 0.01
  • Stochastic Oscillator
  • TYRA 11.68
  • HLF 73.95

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

About HLF Herbalife Ltd.

Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management; targeted nutrition; Energy, Sports, and Fitness; Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Mexico, South and Central America, EMEA, Asia-Pacific, and China.

Share on Social Networks: